

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.47279637 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.44080741 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.44080741 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.99661273 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.45602809 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.45602809 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.38402425 |
| 8 | positive thymic T cell selection (GO:0045059) | 5.15634245 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.98455150 |
| 10 | detection of other organism (GO:0098543) | 4.87640238 |
| 11 | detection of bacterium (GO:0016045) | 4.81286952 |
| 12 | leukocyte aggregation (GO:0070486) | 4.48514356 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.36741998 |
| 14 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.13329853 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 4.10299538 |
| 16 | thymic T cell selection (GO:0045061) | 4.08601597 |
| 17 | positive T cell selection (GO:0043368) | 4.07498837 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.05081584 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.03638389 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.00014683 |
| 21 | negative thymic T cell selection (GO:0045060) | 3.95113117 |
| 22 | negative T cell selection (GO:0043383) | 3.88108880 |
| 23 | positive regulation of histone deacetylation (GO:0031065) | 3.86787492 |
| 24 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.84038284 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81157395 |
| 26 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.80766824 |
| 27 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.72680976 |
| 28 | T cell selection (GO:0045058) | 3.71955678 |
| 29 | response to interleukin-15 (GO:0070672) | 3.67141249 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.64930086 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.61581851 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.58194330 |
| 33 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.58052959 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 3.57965431 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55810683 |
| 36 | tolerance induction (GO:0002507) | 3.55266365 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.55126247 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.52063246 |
| 39 | detection of molecule of bacterial origin (GO:0032490) | 3.49621514 |
| 40 | germinal center formation (GO:0002467) | 3.49154472 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.45972839 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.45547456 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 3.45268765 |
| 44 | regulation of T cell tolerance induction (GO:0002664) | 3.39660322 |
| 45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39169575 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.34906280 |
| 47 | response to host immune response (GO:0052572) | 3.34906280 |
| 48 | T cell migration (GO:0072678) | 3.34430819 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 3.30757434 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28895648 |
| 51 | leukocyte cell-cell adhesion (GO:0007159) | 3.28610104 |
| 52 | response to muramyl dipeptide (GO:0032495) | 3.28441369 |
| 53 | regulation of tolerance induction (GO:0002643) | 3.28139317 |
| 54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25663259 |
| 55 | defense response to protozoan (GO:0042832) | 3.22731048 |
| 56 | response to host defenses (GO:0052200) | 3.16528143 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16528143 |
| 58 | response to host (GO:0075136) | 3.16528143 |
| 59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16345347 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 3.09070613 |
| 61 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.08212570 |
| 62 | negative regulation of innate immune response (GO:0045824) | 3.06090632 |
| 63 | macrophage activation (GO:0042116) | 3.05783280 |
| 64 | neutrophil activation (GO:0042119) | 3.05577231 |
| 65 | microglial cell activation (GO:0001774) | 3.02054830 |
| 66 | megakaryocyte development (GO:0035855) | 3.01204391 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99521385 |
| 68 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99521385 |
| 69 | natural killer cell differentiation (GO:0001779) | 2.97748466 |
| 70 | respiratory burst (GO:0045730) | 2.97411616 |
| 71 | positive regulation of protein deacetylation (GO:0090312) | 2.97186107 |
| 72 | negative regulation of type 2 immune response (GO:0002829) | 2.96871889 |
| 73 | response to peptidoglycan (GO:0032494) | 2.96595905 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 2.96419736 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 2.93679324 |
| 76 | positive regulation of granulocyte differentiation (GO:0030854) | 2.92369826 |
| 77 | negative regulation of interleukin-6 production (GO:0032715) | 2.90927620 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89244494 |
| 79 | T cell homeostasis (GO:0043029) | 2.88924361 |
| 80 | interferon-gamma production (GO:0032609) | 2.88520879 |
| 81 | granulocyte activation (GO:0036230) | 2.88468772 |
| 82 | regulation of mast cell activation (GO:0033003) | 2.87929380 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87654521 |
| 84 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86058076 |
| 85 | mannose metabolic process (GO:0006013) | 2.85744626 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 2.84673425 |
| 87 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.83343990 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.82382665 |
| 89 | positive regulation of interferon-alpha production (GO:0032727) | 2.81559075 |
| 90 | cellular extravasation (GO:0045123) | 2.81388857 |
| 91 | T cell receptor signaling pathway (GO:0050852) | 2.79402890 |
| 92 | regulation of erythrocyte differentiation (GO:0045646) | 2.79024179 |
| 93 | response to type I interferon (GO:0034340) | 2.77635896 |
| 94 | positive regulation by symbiont of host defense response (GO:0052509) | 2.77511429 |
| 95 | modulation by symbiont of host defense response (GO:0052031) | 2.77511429 |
| 96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.77511429 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.77511429 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.77511429 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 2.77511429 |
| 100 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76004954 |
| 101 | cellular response to zinc ion (GO:0071294) | 2.75824090 |
| 102 | T cell proliferation (GO:0042098) | 2.75198697 |
| 103 | neutrophil mediated immunity (GO:0002446) | 2.74192978 |
| 104 | cellular response to interleukin-15 (GO:0071350) | 2.73886438 |
| 105 | response to fungus (GO:0009620) | 2.72834079 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 2.72466658 |
| 107 | lymphocyte homeostasis (GO:0002260) | 2.71001834 |
| 108 | negative regulation of bone resorption (GO:0045779) | 2.70922581 |
| 109 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.70585815 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 2.70043337 |
| 111 | mature B cell differentiation (GO:0002335) | 2.68654611 |
| 112 | myeloid dendritic cell differentiation (GO:0043011) | 2.68159862 |
| 113 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67582758 |
| 114 | T cell costimulation (GO:0031295) | 2.64996002 |
| 115 | type I interferon signaling pathway (GO:0060337) | 2.64724933 |
| 116 | cellular response to type I interferon (GO:0071357) | 2.64724933 |
| 117 | adaptation of signaling pathway (GO:0023058) | 2.64681862 |
| 118 | immunoglobulin mediated immune response (GO:0016064) | 2.63230915 |
| 119 | erythrocyte maturation (GO:0043249) | 2.61591450 |
| 120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61398607 |
| 121 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60520606 |
| 122 | positive regulation of interleukin-2 production (GO:0032743) | 2.59539322 |
| 123 | lymphocyte costimulation (GO:0031294) | 2.59320669 |
| 124 | defense response to fungus (GO:0050832) | 2.58372514 |
| 125 | regulation of response to interferon-gamma (GO:0060330) | 2.54375315 |
| 126 | myeloid cell activation involved in immune response (GO:0002275) | 2.54299878 |
| 127 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.54101521 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.52345190 |
| 129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.52345190 |
| 130 | positive regulation of antigen processing and presentation (GO:0002579) | 2.51869955 |
| 131 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.50593219 |
| 132 | Peyers patch development (GO:0048541) | 2.50593219 |
| 133 | activated T cell proliferation (GO:0050798) | 2.49583847 |
| 134 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.49238745 |
| 135 | positive regulation of isotype switching (GO:0045830) | 2.48846978 |
| 136 | leukocyte degranulation (GO:0043299) | 2.48123268 |
| 137 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.47042395 |
| 138 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.46647670 |
| 139 | response to protozoan (GO:0001562) | 2.44826133 |
| 140 | sequestering of metal ion (GO:0051238) | 2.44572053 |
| 141 | response to laminar fluid shear stress (GO:0034616) | 2.43460355 |
| 142 | mast cell activation (GO:0045576) | 2.42766967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.16813762 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.66262277 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.56149193 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49433364 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41082436 |
| 6 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.37992841 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.32873372 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.00947287 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93239743 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73693886 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.65239606 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62810296 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.61361195 |
| 14 | * MAF_26560356_Chip-Seq_TH1_Human | 2.57174708 |
| 15 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.56594759 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.46471510 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41131024 |
| 18 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.38590594 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.35348502 |
| 20 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.34503137 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32244882 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32057235 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31846673 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.31299494 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.31279339 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.29991297 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.29942456 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.27501291 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23835467 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23041770 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.22453393 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19238741 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.18017771 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.13841992 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10880060 |
| 36 | * MYB_26560356_Chip-Seq_TH1_Human | 2.07585610 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 2.03646502 |
| 38 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02243739 |
| 39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.92726534 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89002641 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88431244 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84778139 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.79004975 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78672738 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73582499 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.70211564 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.68702094 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68360752 |
| 49 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.64537670 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62060827 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57586759 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57530960 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56932888 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.56427105 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47822866 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47213528 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44670036 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43969141 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43070512 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40757487 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38713688 |
| 62 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37789416 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35873975 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35785604 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.32994536 |
| 66 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.30345818 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29797606 |
| 68 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.28973744 |
| 69 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25330309 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25138280 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25076372 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22951049 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22071077 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18631418 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16495995 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16269100 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16088546 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13729580 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13177403 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12784635 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12635840 |
| 82 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11269638 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10553188 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07966490 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07254220 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07207136 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07074881 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05742303 |
| 89 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05407099 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04344581 |
| 91 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04174833 |
| 92 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01814974 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01288953 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00959349 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00671445 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97701218 |
| 97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97645458 |
| 98 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97127160 |
| 99 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.96223073 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96024254 |
| 101 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94893164 |
| 102 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94599107 |
| 103 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94332623 |
| 104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93789689 |
| 105 | * P68_20966046_ChIP-Seq_HELA_Human | 0.93253997 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92310252 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92113000 |
| 108 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.91924745 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91636330 |
| 110 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89600767 |
| 111 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.88978745 |
| 112 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88445977 |
| 113 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87918656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.63549886 |
| 2 | MP0000685_abnormal_immune_system | 3.21214548 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.19730558 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.03392270 |
| 5 | MP0003436_decreased_susceptibility_to | 2.86024896 |
| 6 | MP0005671_abnormal_response_to | 2.73213287 |
| 7 | MP0001800_abnormal_humoral_immune | 2.71110875 |
| 8 | MP0005387_immune_system_phenotype | 2.70992051 |
| 9 | MP0001790_abnormal_immune_system | 2.70992051 |
| 10 | MP0009278_abnormal_bone_marrow | 2.65324226 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.48984860 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.45168108 |
| 13 | MP0004510_myositis | 2.42774981 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.35030433 |
| 15 | MP0002723_abnormal_immune_serum | 2.34800037 |
| 16 | MP0001819_abnormal_immune_cell | 2.32878777 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.32503629 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.32388888 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.29584140 |
| 20 | MP0002398_abnormal_bone_marrow | 2.28326628 |
| 21 | MP0008260_abnormal_autophagy | 2.26745005 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.22198486 |
| 23 | MP0005025_abnormal_response_to | 2.22075141 |
| 24 | MP0002419_abnormal_innate_immunity | 2.17439363 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.14892793 |
| 26 | MP0005451_abnormal_body_composition | 2.07914197 |
| 27 | MP0002396_abnormal_hematopoietic_system | 2.06693625 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 2.06104753 |
| 29 | MP0001873_stomach_inflammation | 2.03624541 |
| 30 | MP0009785_altered_susceptibility_to | 2.03166031 |
| 31 | MP0003866_abnormal_defecation | 2.03133564 |
| 32 | MP0004947_skin_inflammation | 1.99543710 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.99445354 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.99445354 |
| 35 | MP0000716_abnormal_immune_system | 1.99258216 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.89713367 |
| 37 | MP0002132_abnormal_respiratory_system | 1.88576920 |
| 38 | MP0002405_respiratory_system_inflammati | 1.84208929 |
| 39 | MP0002722_abnormal_immune_system | 1.81034351 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.78583256 |
| 41 | MP0008961_abnormal_basal_metabolism | 1.76417612 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.75131330 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.74077459 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.73861555 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.72952483 |
| 46 | MP0002429_abnormal_blood_cell | 1.69745724 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.68629962 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.61558645 |
| 49 | MP0005310_abnormal_salivary_gland | 1.58318963 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.56631184 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.56275484 |
| 52 | MP0002006_tumorigenesis | 1.55410873 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.54127264 |
| 54 | MP0004381_abnormal_hair_follicle | 1.53422598 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.51101709 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.47552560 |
| 57 | MP0010307_abnormal_tumor_latency | 1.44264508 |
| 58 | MP0003045_fibrosis | 1.40137661 |
| 59 | MP0006082_CNS_inflammation | 1.39389542 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.38987157 |
| 61 | MP0001853_heart_inflammation | 1.31290621 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.30531271 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.28915681 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.28416455 |
| 65 | MP0003724_increased_susceptibility_to | 1.25898644 |
| 66 | MP0000858_altered_metastatic_potential | 1.19672651 |
| 67 | MP0004883_abnormal_blood_vessel | 1.13765721 |
| 68 | MP0002933_joint_inflammation | 1.07599458 |
| 69 | MP0000490_abnormal_crypts_of | 1.04045034 |
| 70 | MP0002693_abnormal_pancreas_physiology | 1.02633593 |
| 71 | MP0008469_abnormal_protein_level | 1.02134519 |
| 72 | MP0003690_abnormal_glial_cell | 1.00268559 |
| 73 | MP0001851_eye_inflammation | 0.94278513 |
| 74 | MP0003448_altered_tumor_morphology | 0.93290156 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.90895377 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.90069590 |
| 77 | MP0002735_abnormal_chemical_nociception | 0.82770164 |
| 78 | MP0005023_abnormal_wound_healing | 0.82269858 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.81905751 |
| 80 | MP0005164_abnormal_response_to | 0.81783117 |
| 81 | MP0005166_decreased_susceptibility_to | 0.77119485 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.76381298 |
| 83 | MP0005390_skeleton_phenotype | 0.74573781 |
| 84 | MP0001663_abnormal_digestive_system | 0.74360405 |
| 85 | MP0002009_preneoplasia | 0.73964600 |
| 86 | MP0001348_abnormal_lacrimal_gland | 0.73930111 |
| 87 | MP0009763_increased_sensitivity_to | 0.72377291 |
| 88 | MP0002928_abnormal_bile_duct | 0.72261925 |
| 89 | MP0000371_diluted_coat_color | 0.70188040 |
| 90 | MP0003091_abnormal_cell_migration | 0.70077269 |
| 91 | MP0008004_abnormal_stomach_pH | 0.70048078 |
| 92 | MP0002998_abnormal_bone_remodeling | 0.69297734 |
| 93 | MP0005621_abnormal_cell_physiology | 0.68474961 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.66390742 |
| 95 | MP0001270_distended_abdomen | 0.66257262 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.65274247 |
| 97 | MP0003828_pulmonary_edema | 0.64133837 |
| 98 | MP0000343_altered_response_to | 0.61800398 |
| 99 | MP0003795_abnormal_bone_structure | 0.61435945 |
| 100 | MP0009764_decreased_sensitivity_to | 0.60995339 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.60711713 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 0.60094576 |
| 103 | MP0004130_abnormal_muscle_cell | 0.59931772 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.59113429 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.58446924 |
| 106 | MP0000313_abnormal_cell_death | 0.58093327 |
| 107 | MP0009840_abnormal_foam_cell | 0.58036349 |
| 108 | MP0000249_abnormal_blood_vessel | 0.58019792 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.57380931 |
| 110 | MP0000609_abnormal_liver_physiology | 0.57231406 |
| 111 | MP0008874_decreased_physiological_sensi | 0.55581072 |
| 112 | MP0005083_abnormal_biliary_tract | 0.55579742 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.55118564 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54673182 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.53929004 |
| 116 | MP0004858_abnormal_nervous_system | 0.53573454 |
| 117 | MP0003075_altered_response_to | 0.53416640 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.53385680 |
| 119 | MP0000604_amyloidosis | 0.52954483 |
| 120 | MP0009931_abnormal_skin_appearance | 0.52579431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.98038135 |
| 2 | Orchitis (HP:0100796) | 4.55236159 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.27978833 |
| 4 | Optic neuritis (HP:0100653) | 4.27978833 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.25811406 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.17846233 |
| 7 | Abnormality of the fingertips (HP:0001211) | 4.05709627 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.01551160 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.82672713 |
| 10 | Nasal polyposis (HP:0100582) | 3.81956768 |
| 11 | Chronic otitis media (HP:0000389) | 3.76269761 |
| 12 | Recurrent viral infections (HP:0004429) | 3.76144151 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45319241 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45319241 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.43331464 |
| 16 | Encephalitis (HP:0002383) | 3.35428426 |
| 17 | Hypochromic anemia (HP:0001931) | 3.29909218 |
| 18 | IgM deficiency (HP:0002850) | 3.29534560 |
| 19 | Hypochromic microcytic anemia (HP:0004840) | 3.27380764 |
| 20 | Cellulitis (HP:0100658) | 3.22816187 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.17732284 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.15486133 |
| 23 | Colitis (HP:0002583) | 3.15371364 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 3.14933468 |
| 25 | Recurrent bronchitis (HP:0002837) | 3.13082747 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11859826 |
| 27 | Recurrent skin infections (HP:0001581) | 3.08907416 |
| 28 | Thrombocytosis (HP:0001894) | 3.06494112 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.02820466 |
| 30 | Increased IgE level (HP:0003212) | 3.00581042 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.99646246 |
| 32 | Urticaria (HP:0001025) | 2.98112444 |
| 33 | Prolonged bleeding time (HP:0003010) | 2.96795613 |
| 34 | Pustule (HP:0200039) | 2.94235599 |
| 35 | T lymphocytopenia (HP:0005403) | 2.93639525 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.91721882 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.88013906 |
| 38 | Meningitis (HP:0001287) | 2.87714507 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.84704380 |
| 40 | Myositis (HP:0100614) | 2.81321635 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.79935365 |
| 42 | Papilloma (HP:0012740) | 2.72245897 |
| 43 | Verrucae (HP:0200043) | 2.72245897 |
| 44 | Abnormality of T cells (HP:0002843) | 2.67248531 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.66534516 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66168407 |
| 47 | Obstructive lung disease (HP:0006536) | 2.63940749 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63940749 |
| 49 | Episodic fever (HP:0001954) | 2.61833363 |
| 50 | Gingivitis (HP:0000230) | 2.61255669 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.60492080 |
| 52 | Abnormal platelet function (HP:0011869) | 2.58836024 |
| 53 | Impaired platelet aggregation (HP:0003540) | 2.58836024 |
| 54 | Vasculitis (HP:0002633) | 2.58167282 |
| 55 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.53370476 |
| 56 | Hyperacusis (HP:0010780) | 2.50198620 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.49632805 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.45928853 |
| 59 | Epistaxis (HP:0000421) | 2.43690628 |
| 60 | Anorexia (HP:0002039) | 2.40032442 |
| 61 | Pulmonary embolism (HP:0002204) | 2.37518779 |
| 62 | Abnormality of B cell number (HP:0010975) | 2.36881825 |
| 63 | B lymphocytopenia (HP:0010976) | 2.36881825 |
| 64 | Chest pain (HP:0100749) | 2.36815136 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.35480351 |
| 66 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.33626039 |
| 67 | Microcytic anemia (HP:0001935) | 2.33277004 |
| 68 | Petechiae (HP:0000967) | 2.30928131 |
| 69 | Increased IgM level (HP:0003496) | 2.27777897 |
| 70 | Periodontitis (HP:0000704) | 2.26962940 |
| 71 | Stomatitis (HP:0010280) | 2.23634039 |
| 72 | Lymphopenia (HP:0001888) | 2.23534297 |
| 73 | Osteomyelitis (HP:0002754) | 2.23211130 |
| 74 | Leukocytosis (HP:0001974) | 2.22450821 |
| 75 | Eosinophilia (HP:0001880) | 2.21713615 |
| 76 | Increased serum ferritin (HP:0003281) | 2.19773802 |
| 77 | Slow saccadic eye movements (HP:0000514) | 2.19771373 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.18914291 |
| 79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18790083 |
| 80 | Purpura (HP:0000979) | 2.17767507 |
| 81 | Restrictive lung disease (HP:0002091) | 2.15506246 |
| 82 | Viral hepatitis (HP:0006562) | 2.14752215 |
| 83 | Amyloidosis (HP:0011034) | 2.13534777 |
| 84 | Peritonitis (HP:0002586) | 2.11964954 |
| 85 | Emphysema (HP:0002097) | 2.11939651 |
| 86 | Hypertensive crisis (HP:0100735) | 2.08288967 |
| 87 | Dysostosis multiplex (HP:0000943) | 2.07111427 |
| 88 | Hemoptysis (HP:0002105) | 2.06557757 |
| 89 | Gastrointestinal stroma tumor (HP:0100723) | 2.06467286 |
| 90 | Abnormality of the pleura (HP:0002103) | 2.06406641 |
| 91 | Abnormal platelet volume (HP:0011876) | 2.05949337 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.05702735 |
| 93 | Increased density of long bones (HP:0006392) | 2.03291103 |
| 94 | Loss of speech (HP:0002371) | 2.03141706 |
| 95 | Arterial thrombosis (HP:0004420) | 2.02895546 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.02867723 |
| 97 | Abnormality of the peritoneum (HP:0002585) | 2.02756152 |
| 98 | Macroorchidism (HP:0000053) | 2.02107208 |
| 99 | Hepatosplenomegaly (HP:0001433) | 1.99851999 |
| 100 | Mucopolysacchariduria (HP:0008155) | 1.98483501 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98483501 |
| 102 | Metaphyseal cupping (HP:0003021) | 1.98448790 |
| 103 | Hematochezia (HP:0002573) | 1.97569126 |
| 104 | Acne (HP:0001061) | 1.97148245 |
| 105 | Pulmonary infiltrates (HP:0002113) | 1.96100136 |
| 106 | Premature loss of primary teeth (HP:0006323) | 1.94012477 |
| 107 | Thyroiditis (HP:0100646) | 1.93417102 |
| 108 | Hemorrhage of the eye (HP:0011885) | 1.93064861 |
| 109 | Hypercortisolism (HP:0001578) | 1.93034493 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92736786 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92736786 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92736786 |
| 113 | Granulocytopenia (HP:0001913) | 1.92675735 |
| 114 | Recurrent sinusitis (HP:0011108) | 1.92456579 |
| 115 | Papilledema (HP:0001085) | 1.91788462 |
| 116 | Severe short stature (HP:0003510) | 1.91389278 |
| 117 | Gingival bleeding (HP:0000225) | 1.91050009 |
| 118 | Gangrene (HP:0100758) | 1.89974063 |
| 119 | Abnormality of eosinophils (HP:0001879) | 1.88813139 |
| 120 | Reticulocytosis (HP:0001923) | 1.87907604 |
| 121 | Fatigue (HP:0012378) | 1.87770941 |
| 122 | Acute hepatic failure (HP:0006554) | 1.87246790 |
| 123 | Skin ulcer (HP:0200042) | 1.86709174 |
| 124 | Glomerulopathy (HP:0100820) | 1.86205314 |
| 125 | Polycythemia (HP:0001901) | 1.84372072 |
| 126 | Bicuspid aortic valve (HP:0001647) | 1.84061679 |
| 127 | Sepsis (HP:0100806) | 1.83730882 |
| 128 | Poikilocytosis (HP:0004447) | 1.83681117 |
| 129 | Thoracic kyphosis (HP:0002942) | 1.83511026 |
| 130 | Increased cerebral lipofuscin (HP:0011813) | 1.83426369 |
| 131 | Abnormality of the thoracic spine (HP:0100711) | 1.83382552 |
| 132 | Abnormality of the endocardium (HP:0004306) | 1.81540783 |
| 133 | Polygenic inheritance (HP:0010982) | 1.80949052 |
| 134 | IgA deficiency (HP:0002720) | 1.80591388 |
| 135 | Chronic sinusitis (HP:0011109) | 1.78508488 |
| 136 | Thoracolumbar scoliosis (HP:0002944) | 1.78227615 |
| 137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78074224 |
| 138 | Vacuolated lymphocytes (HP:0001922) | 1.75790116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.99729496 |
| 2 | EEF2K | 3.35281360 |
| 3 | PRPF4B | 3.01765643 |
| 4 | TRIB3 | 2.82567405 |
| 5 | JAK3 | 2.46460008 |
| 6 | TYK2 | 2.45380547 |
| 7 | PKN2 | 2.42197614 |
| 8 | MAP3K10 | 2.24127821 |
| 9 | IRAK4 | 2.09331665 |
| 10 | RIPK4 | 2.07460800 |
| 11 | ZAP70 | 2.02980509 |
| 12 | JAK1 | 1.98225818 |
| 13 | ERN1 | 1.93552113 |
| 14 | TAOK3 | 1.93343985 |
| 15 | EPHB1 | 1.85479160 |
| 16 | MAP3K14 | 1.84839095 |
| 17 | TBK1 | 1.84467542 |
| 18 | GRK6 | 1.84035983 |
| 19 | BTK | 1.76711464 |
| 20 | SIK2 | 1.73752042 |
| 21 | IKBKE | 1.65518405 |
| 22 | ITK | 1.64790238 |
| 23 | STK10 | 1.61285162 |
| 24 | TTN | 1.60841547 |
| 25 | TXK | 1.57658323 |
| 26 | FGFR4 | 1.56503025 |
| 27 | MAP3K3 | 1.53949811 |
| 28 | RIPK1 | 1.52659056 |
| 29 | PTK6 | 1.50755060 |
| 30 | SYK | 1.48015482 |
| 31 | LRRK2 | 1.47048852 |
| 32 | MAP3K11 | 1.46311972 |
| 33 | KIT | 1.40852724 |
| 34 | BLK | 1.40168308 |
| 35 | CDK12 | 1.39871444 |
| 36 | MAP3K13 | 1.39725790 |
| 37 | MAP2K3 | 1.36620315 |
| 38 | FES | 1.35549228 |
| 39 | SMG1 | 1.33696780 |
| 40 | HCK | 1.32324988 |
| 41 | FGFR3 | 1.31279794 |
| 42 | FLT3 | 1.27997971 |
| 43 | JAK2 | 1.27697472 |
| 44 | FGR | 1.27670597 |
| 45 | HIPK2 | 1.26777531 |
| 46 | LCK | 1.15643465 |
| 47 | CSK | 1.13746599 |
| 48 | TEC | 1.08807869 |
| 49 | MAP3K2 | 1.06462374 |
| 50 | IKBKB | 1.03919180 |
| 51 | CDC42BPA | 1.02504964 |
| 52 | PIM1 | 1.00474828 |
| 53 | MARK3 | 0.98869808 |
| 54 | RPS6KA2 | 0.96873801 |
| 55 | RET | 0.96630247 |
| 56 | CSF1R | 0.94551987 |
| 57 | MAP3K6 | 0.93997127 |
| 58 | PRKCH | 0.91834559 |
| 59 | IRAK3 | 0.90930624 |
| 60 | TAOK2 | 0.90012762 |
| 61 | ICK | 0.88614608 |
| 62 | EPHA3 | 0.88057693 |
| 63 | ALK | 0.87601660 |
| 64 | TGFBR2 | 0.87128501 |
| 65 | YES1 | 0.86571418 |
| 66 | TRPM7 | 0.86494256 |
| 67 | CHUK | 0.85293492 |
| 68 | MAP3K7 | 0.84617088 |
| 69 | PDPK1 | 0.84564282 |
| 70 | MAPKAPK3 | 0.83589408 |
| 71 | IRAK2 | 0.82386546 |
| 72 | MAPK12 | 0.80187216 |
| 73 | SIK1 | 0.78413104 |
| 74 | SCYL2 | 0.77206967 |
| 75 | CAMK1G | 0.75527759 |
| 76 | RPS6KA4 | 0.74650028 |
| 77 | RPS6KA6 | 0.73681605 |
| 78 | TAOK1 | 0.71260259 |
| 79 | MAP3K1 | 0.71151368 |
| 80 | RPS6KC1 | 0.69734981 |
| 81 | RPS6KL1 | 0.69734981 |
| 82 | CAMKK2 | 0.67085367 |
| 83 | NEK2 | 0.66653037 |
| 84 | CAMK1D | 0.64633037 |
| 85 | MATK | 0.62992427 |
| 86 | IRAK1 | 0.62912645 |
| 87 | RPS6KB2 | 0.62493504 |
| 88 | LYN | 0.60857852 |
| 89 | BMPR2 | 0.60786778 |
| 90 | BRD4 | 0.59599488 |
| 91 | BMX | 0.59115078 |
| 92 | SGK3 | 0.58606423 |
| 93 | FYN | 0.57564307 |
| 94 | CLK1 | 0.56904691 |
| 95 | TESK2 | 0.56332345 |
| 96 | TNK2 | 0.54488685 |
| 97 | NLK | 0.54074467 |
| 98 | KSR2 | 0.53757243 |
| 99 | MAP2K6 | 0.53687728 |
| 100 | MAPK7 | 0.53147026 |
| 101 | PDK1 | 0.52798205 |
| 102 | PRKD2 | 0.51436168 |
| 103 | PASK | 0.49084342 |
| 104 | PDGFRB | 0.48882999 |
| 105 | PRKCQ | 0.46871206 |
| 106 | STK38 | 0.46760773 |
| 107 | MARK2 | 0.46741675 |
| 108 | MAP2K2 | 0.45730857 |
| 109 | PTK2 | 0.44267969 |
| 110 | STK4 | 0.43657235 |
| 111 | MTOR | 0.41842384 |
| 112 | CAMKK1 | 0.41825534 |
| 113 | CDK4 | 0.41698036 |
| 114 | CDK6 | 0.41334054 |
| 115 | NTRK1 | 0.40205130 |
| 116 | MAPK11 | 0.39193514 |
| 117 | MAPKAPK2 | 0.38565462 |
| 118 | PTK2B | 0.36988235 |
| 119 | SIK3 | 0.36663092 |
| 120 | PRKG2 | 0.36501959 |
| 121 | PDGFRA | 0.36148333 |
| 122 | DYRK1B | 0.34942690 |
| 123 | STK11 | 0.34821970 |
| 124 | MAP3K8 | 0.34065857 |
| 125 | MAP2K4 | 0.31163935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.63823450 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45514167 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30593844 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25930085 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99781975 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92990938 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83183326 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.78874171 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.78085730 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.77910830 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73075477 |
| 12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70888995 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67205976 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61539264 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61194968 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60049626 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58480605 |
| 18 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.53099657 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52181782 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.48859327 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48757740 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48130559 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47862707 |
| 24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.47078055 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43479247 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41826035 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.39942811 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38960207 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37091000 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.36999058 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32285366 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31502536 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28745496 |
| 34 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.28706147 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.28000093 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27220393 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.22753148 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21540006 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.19970648 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18031789 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.15894515 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15028961 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14044591 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.11587307 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11487401 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.09849389 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09805198 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08966981 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08115891 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03673527 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00336251 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.97838060 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96356274 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.95726098 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.90678139 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89967429 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87716939 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.86742510 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85060695 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81004555 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.80809272 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80138129 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77394627 |
| 64 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76587138 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75960322 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.75720758 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75614803 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75328097 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.72941393 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72882194 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72535074 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72531214 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.72178744 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71998177 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70706910 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70519043 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.69883971 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69830711 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.69753616 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67374354 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67260861 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65416000 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65299224 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65285311 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64255287 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.62525450 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61487222 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.61149853 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60750205 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60307710 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59704335 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59283988 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59002402 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58803254 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57254693 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57107951 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56710520 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56004970 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55391429 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55353270 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54858195 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53341550 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53339461 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52992355 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52515627 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52424527 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50864742 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48430763 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47890640 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.45700926 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45217228 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44917349 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43155095 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42794001 |

